A detailed history of Vivaldi Capital Management LP transactions in Pfizer Inc stock. As of the latest transaction made, Vivaldi Capital Management LP holds 14,109 shares of PFE stock, worth $357,945. This represents 0.12% of its overall portfolio holdings.

Number of Shares
14,109
Previous 13,780 2.39%
Holding current value
$357,945
Previous $385,000 5.97%
% of portfolio
0.12%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $9,113 - $10,327
329 Added 2.39%
14,109 $408,000
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $130,796 - $153,268
-5,178 Reduced 27.31%
13,780 $385,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $24,983 - $28,689
-965 Reduced 4.84%
18,958 $526,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $34,360 - $44,631
-1,315 Reduced 6.19%
19,923 $573,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $11,841 - $13,841
-369 Reduced 1.71%
21,238 $704,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $26,512 - $30,673
734 Added 3.52%
21,607 $792,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $925,704 - $1.21 Million
-23,501 Reduced 52.96%
20,873 $851,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $94,856 - $123,824
2,272 Added 5.4%
44,374 $2.27 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $10,852 - $13,248
-248 Reduced 0.59%
42,102 $1.78 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $210,641 - $249,754
4,527 Added 11.97%
42,350 $2.22 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $22,646 - $28,061
-495 Reduced 1.29%
37,823 $1.89 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $3,222 - $4,777
-78 Reduced 0.2%
38,318 $2.26 Million
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $9,734 - $12,504
-248 Reduced 0.64%
38,396 $1.65 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $9,192 - $10,414
-256 Reduced 0.66%
38,644 $1.87 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $201,073 - $226,771
-6,004 Reduced 13.37%
38,900 $1.56 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $48,355 - $56,731
-1,523 Reduced 3.28%
44,904 $1.73 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $51,384 - $62,337
-1,706 Reduced 3.54%
46,427 $1.78 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $15,217 - $21,743
-563 Reduced 1.16%
48,133 $1.57 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $3,094 - $3,511
94 Added 0.19%
48,696 $1.91 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $49,222 - $63,826
1,515 Added 3.22%
48,602 $1.75 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $1.04 Million - $1.17 Million
28,143 Added 148.56%
47,087 $2.04 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $294,262 - $323,296
7,847 Added 70.71%
18,944 $805,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $145,685 - $166,097
3,787 Added 51.81%
11,097 $484,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $1,689 - $2,048
49 Added 0.67%
7,310 $322,000
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $28,791 - $30,694
-873 Reduced 10.73%
7,261 $263,000
Q1 2018

May 08, 2018

BUY
$31.91 - $37.02 $14,295 - $16,584
448 Added 5.83%
8,134 $289,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $2,195 - $2,329
66 Added 0.87%
7,686 $278,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $236,220 - $260,223
7,620
7,620 $272,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $142B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vivaldi Capital Management LP Portfolio

Follow Vivaldi Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Vivaldi Capital Management LP with notifications on news.